产品标题 |
产品货号 |
产品规格 |
厂家 |
AIDA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417521 | 1 kit | ORIGENE TECHNOLOGIES |
Aida - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501035 | 1 kit | ORIGENE TECHNOLOGIES |
AIDA Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH317521 | 10 ug | ORIGENE TECHNOLOGIES |
Like-glycosyltransferase (LARGE), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417788 | 100 ug | ORIGENE TECHNOLOGIES |
Like-glycosyltransferase (LARGE), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429220 | 100 ug | ORIGENE TECHNOLOGIES |
Like-glycosyltransferase (LARGE), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408762 | 100 ug | ORIGENE TECHNOLOGIES |
Actin, gamma 2, smooth muscle, enteric (ACTG2) from ORIGENE TECHNOLOGIES | LY419843 | 100 ug | ORIGENE TECHNOLOGIES |
Actinin, alpha 2 (ACTN2) from ORIGENE TECHNOLOGIES | LY420189 | 100 ug | ORIGENE TECHNOLOGIES |
Actinin, alpha 3 (ACTN3) from ORIGENE TECHNOLOGIES | LY420205 | 100 ug | ORIGENE TECHNOLOGIES |
Actinin, alpha 4 (ACTN4) from ORIGENE TECHNOLOGIES | LY417652 | 100 ug | ORIGENE TECHNOLOGIES |
LILRA2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405626 | 1 kit | ORIGENE TECHNOLOGIES |
LILRA3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407003 | 1 kit | ORIGENE TECHNOLOGIES |
LILRA1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410808 | 1 kit | ORIGENE TECHNOLOGIES |
LILRA5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412310 | 1 kit | ORIGENE TECHNOLOGIES |
LILRA6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412965 | 1 kit | ORIGENE TECHNOLOGIES |
LILRA4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN420452 | 1 kit | ORIGENE TECHNOLOGIES |
Lilra5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509283 | 1 kit | ORIGENE TECHNOLOGIES |
Lilra6 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509284 | 1 kit | ORIGENE TECHNOLOGIES |
LILRA1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH310808 | 10 ug | ORIGENE TECHNOLOGIES |
LILRA3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307003 | 10 ug | ORIGENE TECHNOLOGIES |
Actinin, alpha 1 (ACTN1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400447 | 100 ug | ORIGENE TECHNOLOGIES |
Actin-like 7A (ACTL7A) from ORIGENE TECHNOLOGIES | LY416489 | 100 ug | ORIGENE TECHNOLOGIES |
Actin-like 6A (ACTL6A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406076 | 100 ug | ORIGENE TECHNOLOGIES |
Actin-like 6A (ACTL6A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418091 | 100 ug | ORIGENE TECHNOLOGIES |
Actin-like 6A (ACTL6A), transcript variant 3 from ORIGENE TECHNOLOGIES | LY406030 | 100 ug | ORIGENE TECHNOLOGIES |
Actin-like 6A (ACTL6A), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430490 | 100 ug | ORIGENE TECHNOLOGIES |
5-oxoprolinase (ATP-hydrolysing) (OPLAH) from ORIGENE TECHNOLOGIES | LY413711 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase, acidic (CHIA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY411918 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase, acidic (CHIA), transcript variant 4 from ORIGENE TECHNOLOGIES | LY404502 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase 1 (chitotriosidase) (CHIT1) from ORIGENE TECHNOLOGIES | LY401172 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase domain containing 1 (CHID1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY428239 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase domain containing 1 (CHID1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428238 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase domain containing 1 (CHID1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY411400 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase domain containing 1 (CHID1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY428240 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase 3-like 1 (cartilage glycoprotein-39) (CHI3L1) from ORIGENE TECHNOLOGIES | LY420034 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase domain containing 1 (CHID1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY428241 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase 3-like 2 (CHI3L2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418266 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase 3-like 2 (CHI3L2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY400404 | 100 ug | ORIGENE TECHNOLOGIES |
Chitinase 3-like 2 (CHI3L2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422601 | 100 ug | ORIGENE TECHNOLOGIES |
Paraneoplastic antigen like 6A (PNMA6A) from ORIGENE TECHNOLOGIES | LY409808 | 100 ug | ORIGENE TECHNOLOGIES |
Paraneoplastic antigen like 6C (PNMA6C) from ORIGENE TECHNOLOGIES | LY433000 | 100 ug | ORIGENE TECHNOLOGIES |
Paraneoplastic antigen MA1 (PNMA1) from ORIGENE TECHNOLOGIES | LY416921 | 100 ug | ORIGENE TECHNOLOGIES |
Paraneoplastic antigen MA2 (PNMA2) from ORIGENE TECHNOLOGIES | LY416096 | 100 ug | ORIGENE TECHNOLOGIES |
Paraneoplastic antigen MA3 (PNMA3) from ORIGENE TECHNOLOGIES | LY415667 | 100 ug | ORIGENE TECHNOLOGIES |
Paraoxonase 1 (PON1) from ORIGENE TECHNOLOGIES | LY400156 | 100 ug | ORIGENE TECHNOLOGIES |
Paraoxonase 3 (PON3) from ORIGENE TECHNOLOGIES | LY400339 | 100 ug | ORIGENE TECHNOLOGIES |
Paraspeckle component 1 (PSPC1), transcript variant alpha from ORIGENE TECHNOLOGIES | LY420888 | 100 ug | ORIGENE TECHNOLOGIES |
Parathymosin (PTMS) from ORIGENE TECHNOLOGIES | LY419066 | 100 ug | ORIGENE TECHNOLOGIES |
Human arsenic (+3 oxidation state) methyltransferase (AS3MT) from ORIGENE TECHNOLOGIES | TP324597 | 20 ug | ORIGENE TECHNOLOGIES |
DPM3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH312952 | 10 ug | ORIGENE TECHNOLOGIES |